Etiometry logo

Etiometry

by Etiometry
VISIT OFFICIAL WEBSITE →

OVERVIEW

Clinical intelligence platform for Intensive Care Units (ICUs) that aggregates real-time patient data, provides FDA-cleared risk analytics, and automates clinical pathways.

The Etiometry Platform is an end-to-end clinical intelligence and data management software solution for the collection, analysis, visualization, and archiving of critical care data. Designed for high-acuity settings like the Intensive Care Unit (ICU), the platform aggregates continuous physiologic data from patient monitors, peripheral devices, and Electronic Health Records (EHRs) into a unified, vendor-neutral dashboard.

Key Capabilities & Features:

  • Data Aggregation and Visualization: Provides a holistic, time-sequenced view of patient data, consolidating information from disparate systems (EHRs, monitors, lab systems) to support timely clinical review.
  • Risk Analytics: Features proprietary, FDA-cleared risk indices (such as IDO2 for Inadequate Oxygen Delivery and IVCO2 for Inadequate CO2 Ventilation) that use advanced algorithms to compute real-time risk assessments, enabling early detection of patient deterioration. Etiometry holds 10 FDA clearances for its platform.
  • Clinical Pathway Automation: Drives consistent, timely adherence to hospital-defined care protocols and workflows (e.g., Extubation Readiness Tests, Vasoactive Weaning) by providing automated flags and decision support.
  • Quality Improvement Application: A clinical database that stores over 150 million hours of de-identified patient data, powering continuous process improvement, clinical research, and quality reporting.

Value Proposition & Outcomes:

The platform has been associated with significant clinical outcomes, including up to a 41% reduction in ICU readmissions, a 36% reduction in ICU Length of Stay (LOS), and a 30% reduction in ventilation time. It is utilized by clinicians via bedside displays, workstations, or remotely through a VPN or Single Sign-On (SSO) within EHRs.

RATING & STATS

User Rating
4.6/5.0
Customers
100+
Founded
2010

KEY FEATURES

  • Real-time Data Aggregation and Visualization (Vendor-Neutral)
  • FDA-Cleared Risk Analytics (IDO2, IVCO2, ACD, HLA)
  • Clinical Pathway Automation
  • Quality Improvement Application/Clinical Database
  • AI-Assistant for Hemodynamic and Respiratory Management
  • Longitudinal Patient Trend Analysis
  • Single Sign-On (SSO) Integration

PRICING

Model: subscription
Enterprise subscription model. Pricing is not publicly disclosed; contact vendor for a quote.

TECHNICAL DETAILS

Deployment: cloud, on_premise
Platforms: web, windows, macos, ios, android, linux
📱 Mobile Apps🔌 API Available

USE CASES

Clinical Decision Support in ICUs (Pediatric and Adult)Early Detection of Patient DeteriorationClinical Research and Quality ImprovementAutomating Clinical Workflows (e.g., Extubation Readiness)Reducing ICU Length of Stay and Readmissions

INTEGRATIONS

EpicCernerMeditechAllscriptsMcKessonGE HealthcarePhilips HealthcareSiemens HealthineersPatient Monitoring SystemsPeripheral Devices

COMPLIANCE & SECURITY

Compliance:
FDA 510(k) ClearedSOC 2 Type 2ISO 27001ISO 13485CE MarkingHealth Canada Licensing
Security Features:
  • 🔒SSO (Single Sign-On)
  • 🔒Fortified Data Protection

SUPPORT & IMPLEMENTATION

Support: email, phone, training
Implementation Time: 1-3 months
Target Company Size: enterprise
TRAINING AVAILABLE

PROS & CONS

✓ Pros:
  • +FDA-cleared proprietary risk algorithms (10 clearances) for proactive care.
  • +Proven clinical outcomes (e.g., reduced LOS, readmissions, ventilation time).
  • +Vendor-neutral data aggregation from all bedside devices and EHRs.
  • +High-level security and compliance (SOC 2, ISO 27001, ISO 13485).
  • +Supports care standardization through automated clinical pathways.
✗ Cons:
  • -Pricing is not publicly disclosed (Enterprise model).
  • -Highly specialized for high-acuity/ICU settings (limited scope).
  • -Implementation requires hospital IT collaboration.

ABOUT ETIOMETRY

BROWSE SOFTWARE IN ICU PREDICTIVE ANALYTICS